Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Based in Center Valley, PA, Avantor, Inc. (NYSE: AVTR) is a global leader in providing mission-critical products and services to customers in diverse industries such as life sciences, healthcare, education and government, as well as advanced technologies and applied materials. Avantor's portfolio includes high-performance chemistries and materials marketed under reputable brand names such as J.T.Baker®, Macron Fine Chemicals™, Rankem™, BeneSphera™, and POCH™. The company's offerings span materials and consumables, equipment and instrumentation, as well as services and specialty procurement.
Operating across three geographical segments—Americas, Europe, and AMEA—Avantor generates a majority of its revenue from the Americas. Recent strategic initiatives include a partnership with Tobin Scientific to support end-to-end biopharma logistics, enhancing Avantor's ability to provide cold chain and ambient storage solutions for lab relocations and sample transport. This collaboration ensures current Good Manufacturing Practice (cGMP) compliance and aims to streamline complex logistics, thereby allowing customers to focus on advancing their research.
In addition to its commitment to operational excellence, Avantor is making strides in sustainability. The company recently introduced an innovative packaging system that optimizes product-to-package ratios, significantly reducing shipping material usage. This system has already saved thousands of pounds of filler material, exemplifying Avantor's dedication to eco-friendly practices.
Financially, Avantor reported net sales of $1.72 billion for Q3 2023, a 7.3% decline compared to the previous year, largely due to organic sales dips and COVID-19 headwinds. Despite these challenges, Avantor achieved more than 110% free cash flow conversion, facilitating ongoing debt reduction. The company also reaffirmed its FY2023 guidance, underscoring its confidence in long-term growth prospects by implementing a new operating model and advancing a $300 million cost optimization initiative.
Avantor’s global footprint gives it access to over 300,000 customer locations in 180+ countries, thereby positioning it as a crucial partner in facilitating scientific breakthroughs and innovation. For more information, visit avantorsciences.com.
Avantor (NYSE: AVTR), a key player in mission-critical products for life sciences and advanced technologies, will participate in the 42nd Annual Cowen Healthcare Conference on March 7, 2022. CEO Michael Stubblefield is set to discuss the company's priorities in a fireside chat at 9:10 a.m. EST. The conversation will be available via a live webcast, with a replay accessible until April 7, 2022.
Avantor serves over 225,000 customer locations across more than 180 countries, playing a vital role in research and production within the biopharma and healthcare sectors.
Avantor, Inc. (NYSE: AVTR) announced the retirement of Board Chairman Rajiv Gupta effective at the end of his term, with no re-election for the upcoming May 12, 2022, annual stockholders meeting. Gupta has been instrumental in Avantor's growth since August 2010, emphasizing vision and value creation. The company plans to announce a new Board chair soon. Gupta expressed pride in Avantor's impact on stakeholders and confidence in its future success under a capable management team.
Avantor, a leading global provider of mission-critical products, reported robust financial results for Q4 2021 and the full year. Q4 net sales reached $1.91 billion, a 6.5% increase, with net income rising to $94 million. The company achieved over 11% organic growth in 2021 and expanded Adjusted EBITDA margin by nearly 190 basis points to 19.8% for the full year. Notably, adjusted EPS surged by approximately 58% to $1.41. The completion of the Masterflex acquisition solidified its fluid management solutions, showcasing commitment to long-term growth strategies.
Avantor has declared a quarterly cash dividend of $0.78 per share on its 6.250% Series A Mandatory Convertible Preferred Stock. This dividend will be paid on February 15, 2022 to shareholders of record as of February 1, 2022. The stock has a liquidation preference of $50. Avantor operates in the biopharma, healthcare, education, and advanced technology sectors, serving over 225,000 customer locations worldwide.
Avantor, Inc. (NYSE: AVTR) is set to release its financial results for Q4 and the full year of 2021 on February 3, 2022, after the market closes. Following this, a conference call will take place on February 4, 2022, at 7:30 a.m. ET to discuss the results. Interested participants can join the call by dialing specific numbers for domestic or international access. A live webcast will also be available on Avantor's investor website, with a replay open until March 3, 2022.
Argosy Healthcare Partners has appointed Greg Mayer to lead portfolio company operations, bringing a wealth of experience from his previous roles at Avantor and Bank of America. Argosy Healthcare Partners, a lower middle market private equity investor, aims to support founder-owned healthcare companies in scaling their businesses. With over $2.3 billion in assets under management, Argosy focuses on life sciences tools and pharmaceutical services, positioning itself to enhance growth opportunities in the healthcare sector.
Avantor, Inc. (NYSE: AVTR) has opened a new single-use logistics hub in Westminster, Massachusetts, enhancing its global biopharma supply chain. This facility, located near the existing manufacturing site in Devens, will streamline raw material storage, quality control, and distribution, enabling better support for the increasing demand for single-use solutions. In 2021, Avantor invested significantly in its single-use capabilities, including acquisitions like RIM Bio and Masterflex. The Westminster site marks Avantor's sixth U.S. location dedicated to single-use solutions, reinforcing its commitment to the biopharmaceutical industry.
Avantor, Inc. (NYSE: AVTR), a major player in mission-critical products for life sciences, will attend the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022. CEO Michael Stubblefield will share insights on the company's priorities starting at 9:45 a.m. PT. A live webcast will be available on the investors section of their website, with a replay accessible until February 10, 2022. Avantor serves a vast customer base, facilitating research and production activities globally, aimed at advancing critical industries.
Avantor, a prominent global provider of critical products and services, will participate in a virtual fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on December 1, 2021. The session, featuring President and CEO Michael Stubblefield, is scheduled to begin at 8:50 a.m. Eastern Time. Investors can access the live webcast through Avantor's website, with a replay available until December 31, 2021. Avantor serves over 225,000 customers in more than 180 countries, playing a vital role in research and development across various industries.
FAQ
What is the current stock price of Avantor (AVTR)?
What is the market cap of Avantor (AVTR)?
What products and services does Avantor provide?
What are Avantor's key brand names?
What geographical regions does Avantor operate in?
How is Avantor contributing to sustainability?
What are Avantor's recent financial highlights?
What is Avantor's new operational strategy?
Who are Avantor's strategic partners?
How does Avantor support scientific research?
Where can I find more information about Avantor?
What are Avantor's plans for future growth?
